In murine allergy models, IL-2 produced by adaptive immune cells has also been shown to augment IL-9 production35, so these results do not exclude other potentiating factors that might act in conjunction with IL-33 in CML mice. The gene discussed is IL2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.